Safety And Efficacy Of Sofosbuvir/Velpatasvir For The Treatment Of Chronic Hepatitis C Infection In Adolescents And Children Aged 3 To 17 Years Old Through 24 Weeks Post-Treatment

HEPATOLOGY(2020)

引用 0|浏览29
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要